The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
Abstract
PURPOSE: Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are associated with major morbidity and mortality, with their burden often extending to longer-term complications such as event recurrence and post-thrombotic syndrome (PTS). Few data exist on the overall economic burden of DVT and PE and their sequelae. A retrospective observational cohort study was conducted to determine the direct medical costs of a DVT or PE patient across the entire continuum of care. SUMMARY: Administrative claims data for patients with a DVT or PE diagnosis (ICD-9-CM code) and patients with possible evidence of PTS between January 1, 1997, and March 31, 2004, were extracted from the PharMetrics Patient-Centric Database, which comprises fully adjudicated medical and pharmaceutical claims for U.S. health care-plan enrollees. Resource utilization and annualized direct medical costs of care for patients with DVT and/or PE were calculated and compared with matched controls. A total of 26,958 patients met the study inclusion criteria. Of the 17,634 patients evaluable for the PTS cohort, 663 (3.8%) patients experienced PTS. Patients with DVT, PE, or DVT and PE had higher annualized direct medical costs before the index (initial) DVT and/or PE event (median: $7227, $6381, and $6771, respectively) than controls (median: $1045). During and after the DVT/PE event, annualized median costs rose to $17,512, $18,901, and $25,554, respectively, compared with $680 in the control group. Annualized median total costs for the PTS group were $20,569 compared with $15,843 in matched controls with DVT and/or PE and no PTS. CONCLUSION: These data suggest that the initial acute DVT or PE event is associated with high total health care costs and that these costs are further increased by subsequent events such as recurrent DVT or PE and PTS. Early detection and appropriate treatment of this high-risk population have the potential for both clinical and economic benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Brandjes, D. P., Büller, H. R., Heijboer, H., Huisman, M. V., de Rijk, M., Jagt, H., & ten Cate, J. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12215-7 · Cited by 873
Cushman, M., Tsai, A. W., White, R. H., Heckbert, S. R., Rosamond, W. D., Enright, P., & Folsom, A. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.018 · Cited by 868
Effect of Postthrombotic Syndrome on Health-Related Quality of Life After Deep Venous Thrombosis
Kahn, S. R., Hirsch, A., & Shrier, I. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1144 · Cited by 379
Prevention and Treatment of Postphlebitic Syndrome: Results of a 3-Part Study
Ginsberg, J. S., Hirsh, J., Julian, J., Vander LaandeVries, M., Magier, D., MacKinnon, B., & Gent, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.17.2105 · Cited by 286
Bergqvist, D., Jendteg, S., Johansen, L., Persson, U., & Odegaard, K. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-6-199703150-00006 · Cited by 252
KAHN, S. R., KEARON, C., JULIAN, J. A., MACKINNON, B., KOVACS, M. J., WELLS, P., CROWTHER, M. A., ANDERSON, D. R., VAN NGUYEN, P., DEMERS, C., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01216.x · Cited by 203
White, R. H., Zhou, H., Kim, J., & Romano, P. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2033 · Cited by 195
Caprini, J. A., Botteman, M. F., Stephens, J. M., Nadipelli, V., Ewing, M. M., Brandt, S., Pashos, C. L., & Cohen, A. T. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00204.x · Cited by 182
Cited by
Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., Gupta, D. K., Prandoni, P., Vedantham, S., Walsh, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000130 · Cited by 636
Grosse, S. D., Nelson, R. E., Nyarko, K. A., Richardson, L. C., & Raskob, G. E. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.033 · Cited by 548
Incidence and cost burden of post-thrombotic syndrome
Ashrani, A. A., & Heit, J. A. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0309-3 · Cited by 295
Post-thrombotic syndrome: a clinical review
Baldwin, M. J., Moore, H. M., Rudarakanchana, N., Gohel, M., & Davies, A. H. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12180 · Cited by 179
How I treat the postthrombotic syndrome
Rabinovich, A., & Kahn, S. R. (2018) · Blood · doi:10.1182/blood-2018-01-785956 · Cited by 107
Metadata
- Authors
- MacDougall, D. A., Feliu, A. L., Boccuzzi, S. J., & Lin, J.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-15
- Volume
- 63
- Issue
- 20_Supplement_6
- Pages
- S5-S15
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W2045201722
- Cited by
- 300
- References
- 12
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. https://app.cochat.ai/papers/10.2146/ajhp060388
- The paper
- MacDougall, D. A., Feliu, A. L., Boccuzzi, S. J., & Lin, J. (2006). Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. American Journal of Health-System Pharmacy. https://doi.org/10.2146/ajhp060388
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.